Compare ETFs: LON:HEAL vs. IBB
LON:HEAL
IBB
Comparison
Average Return
In the past year, LON:HEAL returned a total of 26.98%, which is significantly lower than IBB's 48.26% return. Over the past 5 years, LON:HEAL has had annualized average returns of -2.12%, compared to 3.08% for IBB. These numbers are adjusted for stock splits and assume dividends are reinvested.
Top 25 Holdings
| LON:HEAL - iShares Healthcare Innovation UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | MRNA | Moderna, Inc. | 1.75% |
| 2 | ROIV | Roivant Sciences Ltd. | 1.63% |
| 3 | NTRA | Natera, Inc. | 1.63% |
| 4 | ILMN | Illumina, Inc. | 1.55% |
| 5 | GH | Guardant Health, Inc. | 1.53% |
| 6 | ABBV | AbbVie Inc. | 1.50% |
| 7 | SWX: LONN | Lonza Group AG | 1.49% |
| 8 | RVTY | Revvity, Inc. | 1.47% |
| 9 | CPH: GMAB | Genmab A/S | 1.47% |
| 10 | MRK | Merck & Co., Inc. | 1.46% |
| 11 | SWX: NOVN | Novartis AG | 1.46% |
| 12 | JNJ | Johnson & Johnson | 1.44% |
| 13 | MEDP | Medpace Holdings, Inc. | 1.44% |
| 14 | LON: GSK | GSK plc | 1.43% |
| 15 | EW | Edwards Lifesciences Corporation | 1.43% |
| 16 | AMGN | Amgen Inc. | 1.43% |
| 17 | DHR | Danaher Corporation | 1.43% |
| 18 | ABT | Abbott Laboratories | 1.43% |
| 19 | EBR: ARGX | argenx SE | 1.42% |
| 20 | BIIB | Biogen Inc. | 1.41% |
| 21 | EXEL | Exelixis, Inc. | 1.40% |
| 22 | KRX: 068270 | Celltrion, Inc. | 1.40% |
| 23 | IQV | IQVIA Holdings Inc. | 1.40% |
| 24 | A | Agilent Technologies, Inc. | 1.40% |
| 25 | NBIX | Neurocrine Biosciences, Inc. | 1.39% |
| View LON:HEAL holdings | |||
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.09% |
| 2 | AMGN | Amgen Inc. | 7.90% |
| 3 | GILD | Gilead Sciences, Inc. | 6.94% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.05% |
| 5 | ARGX | argenx SE | 3.73% |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.15% |
| 7 | NTRA | Natera, Inc. | 2.87% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.74% |
| 9 | BIIB | Biogen Inc. | 2.39% |
| 10 | ILMN | Illumina, Inc. | 2.16% |
| 11 | INSM | Insmed Incorporated | 1.81% |
| 12 | UTHR | United Therapeutics Corporation | 1.80% |
| 13 | ONC | BeOne Medicines AG | 1.77% |
| 14 | MRNA | Moderna, Inc. | 1.75% |
| 15 | INCY | Incyte Corporation | 1.72% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.42% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.31% |
| 18 | ASND | Ascendis Pharma A/S | 1.31% |
| 19 | GMAB | Genmab A/S | 1.10% |
| 20 | EXEL | Exelixis, Inc. | 1.05% |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 1.03% |
| 22 | MEDP | Medpace Holdings, Inc. | 0.97% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.95% |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.90% |
| 25 | TECH | Bio-Techne Corporation | 0.89% |
| View IBB holdings | |||